Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
2023 · Nature Medicine · 193 citations
https://doi.org/10.1038/s41591-022-02189-0
C
Cheuk Hong Leung
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
122
Papers
1.9K
Citations
16
h-index
25
i10-index
Cheuk Hong Leung is an academic researcher from Queen Mary Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment. The author has an h-index of 16, co-authored 104 publications.
ORCID: 0000-0002-2531-7739Papers by this author
worksPathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy
2023 · Modern Pathology · 20 citations
https://doi.org/10.1016/j.modpat.2023.100353
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
2024 · npj Precision Oncology · 9 citations
https://doi.org/10.1038/s41698-024-00634-6
Restrictive Ventilatory Defects Following Hematopoietic Stem Cell Transplant Are Associated With Increased Mortality
2025 · Transplantation and Cellular Therapy · 3 citations
https://doi.org/10.1016/j.jtct.2025.02.001
Perspectives from neuro-oncology providers on patient access to electronic records: a survey study
2024 · CNS Oncology · 1 citations
https://doi.org/10.1080/20450907.2024.2352414
Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases
2024 · Discover Oncology · 1 citations
https://doi.org/10.1007/s12672-024-01056-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat